Formation of a Novel Macrocyclic Alkaloid from the Unnatural Farnesyl Diphosphate Analogue Anilinogeranyl Diphosphate by 5-Epi-Aristolochene Synthase

Kathleen A. Rising, Charisse M. Crenshaw, Hyun Jo Koo, Thangaiah Subramanian, Kareem A.H. Chehade, Courtney Starks, Keith D. Allen, Douglas A. Andres, H. Peter Spielmann, Joseph P. Noel, Joe Chappell

Research output: Contribution to journalArticlepeer-review

31 Scopus citations

Abstract

As part of an effort to identify substrate analogs suitable for helping to resolve structural features important for terpene synthases, the inhibition of 5-epi-aristolochene biosynthesis from farnesyl diphosphate (FPP) by the tobacco 5-epi-aristolochene synthase incubated with anilinogeranyl diphosphate (AGPP) was examined. The apparent noncompetitive nature of the inhibition supported further assessment of how AGPP might be bound to crystallographic forms of the enzyme. Surprisingly, the bound form of the inhibitor appeared to have undergone a cyclization event consistent with the native mechanism associated with FPP catalysis. Biocatalytic formation of a novel 13-membered macrocyclic paracyclophane alkaloid was confirmed by high-resolution GC-MS and NMR analysis. This work provides insights into new biosynthetic means for generating novel, functionally diversified, medium-sized terpene alkaloids. (Figure Presented).

Original languageEnglish
Pages (from-to)1729-1736
Number of pages8
JournalACS Chemical Biology
Volume10
Issue number7
DOIs
StatePublished - Jul 17 2015

Bibliographical note

Publisher Copyright:
© 2015 American Chemical Society.

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Medicine

Fingerprint

Dive into the research topics of 'Formation of a Novel Macrocyclic Alkaloid from the Unnatural Farnesyl Diphosphate Analogue Anilinogeranyl Diphosphate by 5-Epi-Aristolochene Synthase'. Together they form a unique fingerprint.

Cite this